Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Obstructive Pulmonary Disease: full-pipeline trial registry
29 of 87 indexed Chronic Obstructive Pulmonary Disease trials are currently recruiting.
Corpus placement: #158 of 28,707 conditions by registered trial count.
87 US clinical trials · 29 currently recruiting · #158 of 28,707 conditions by registered trial count
Chronic Obstructive Pulmonary Disease: 87 US clinical trials tracked, 29 recruiting.
Chronic Obstructive Pulmonary Disease is the subject of 87 registered US clinical trials on ClinicalTrials.gov, 29 of them currently open to new participants. 19 are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most active sponsor is Sanofi, running 6 of these trials.
Enrollment posture brief
Registry condition chronic-obstructive-pulmonary-disease
OPEN 29 | RECR 33% | LATE 19 | EARLY 27 | RANK #158 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Chronic Obstructive Pulmonary Disease lists 29 open slots (33% of 87 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Obstructive Pulmonary Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Obstructive Pulmonary Disease is recruiting below its size-band peers.
29 of 87 indexed trials (33.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Chronic Obstructive Pulmonary Disease trials is spread across many organizations.
Sanofi accounts for 6 of 87 trials (6.9%). 62 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Obstructive Pulmonary Disease enrolment sits around 136 participants.
Median target enrolment is 136 among the 87 trials that report a genuine target (sentinel values excluded). 36 of those (41.4%) plan for fewer than 100 participants.
-
Chronic Obstructive Pulmonary Disease research is mostly interventional.
70 interventional and 17 observational studies make up this index (80.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
87 total, page 2 of 2
NVA237 Versus Placebo 12-week Efficacy Study
Novartis Pharmaceuticals
NCT01709864
Efficacy and Safety Study of QVA149 in COPD Patients
Novartis Pharmaceuticals
NCT02487446
Audio Data Collection for Identification and Classification of Coughing
HealthMode
NCT04326309
HIV-related Accelerated Aging of the Airway Epithelium
Weill Medical College of Cornell University
NCT01974219
PT003 MDI Cardiovascular Safety Study
Pearl Therapeutics
NCT01349803
Anxiety and COPD Evaluation
NYU Langone Health
NCT02740465
Active for Life: Chronic Obstructive Pulmonary Disease
University of Michigan
NCT03201198
Remote Physician Care for Home Hospital Patients
Brigham and Women's Hospital
NCT04080570
Video vs. TTG Respiratory Inhaler Technique Assessment and InstructioN (V-TRaIN)
University of Chicago
NCT02611531
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
Peter Lindenauer, MD
NCT05562037
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Pearl Therapeutics
NCT01085045
Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease
University of North Carolina, Chapel Hill
NCT00903955
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
Treatment Research Institute
NCT02059005
Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD
New York Presbyterian Brooklyn Methodist Hospital
NCT03094806
Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma
Deep Breeze
NCT00542282
Nebulized Hypertonic Saline for Inpatient Use in COPD
OhioHealth
NCT02266875
A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals
NCT00622635
A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
Mylan
NCT02109172
Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
Chiesi Farmaceutici S.p.A.
NCT00640484
COPD Assessment and Management Bundle Versus Usual Care
University of Illinois at Chicago
NCT01833026
Indoor Air Quality and Respiratory Symptoms in Former Smokers
Intermountain Health Care
NCT02956213
A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD
Verona Pharma
NCT06545500
A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary Disease
Verona Pharma
NCT07132983
Modifying Exercise for the COPD Patient
Angela N Fellner PhD CCRP
NCT02143206
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
Kimera Society
NCT02216630
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT00094562
Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients
Louisiana State University Health Sciences Center in New Orleans
NCT01941225
Mindfulness Based Stress Reduction in COPD
Mayo Clinic
NCT01058499
Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease
Dartmouth-Hitchcock Medical Center
NCT01391559
Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies
University of Alabama at Birmingham
NCT03244059
Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease
Breathe Technologies
NCT01372462
Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)
Mayo Clinic
NCT04047810
The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
NCT02845752
Hydrolyzed Casein and Whey Protein Supplementation and the Addition of Leucine to Induce Protein Anabolism in Malnourished COPD Patients
Texas A&M University
NCT01154400
Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD)
Gilead Sciences
NCT02077465
Uphill Walking as Exercise for COPD Patients
VA Office of Research and Development
NCT04026529
Rural Home Hospital: Proof of Concept
Brigham and Women's Hospital
NCT04531280
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 9 |
| Phase 2 | 18 |
| Phase 3 | 15 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Obstructive Pulmonary Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Obstructive Pulmonary Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Obstructive Pulmonary Disease page
87 registered trials, 29 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 29 Chronic Obstructive Pulmonary Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sanofi sponsors the most Chronic Obstructive Pulmonary Disease trials on record, review their full trial history before evaluating a specific study. See Sanofi's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Obstructive Pulmonary Disease condition card totals 87 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.